Search Results - "BRACH DEL PREVER, A"

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol by Ferrari, S., Sundby Hall, K., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., Alvegard, T.A., Brach del Prever, A., Tamburini, A., Alberghini, M., Gandola, L., Mercuri, M., Capanna, R., Mapelli, S., Prete, A., Carli, M., Picci, P., Barbieri, E., Bacci, G., Smeland, S.

“…High-dose chemotherapy (HDT) was added to conventional chemotherapy in Ewing sarcoma family tumor (EFT) patients, poor responders (PRs) to induction…”
Get full text

ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells by VALABREGA, G, FAGIOLI, F, CORSO, S, MADON, E, DEL PREVER, A. Brach, BIASIN, E, LINARI, A, AGLIETTA, M, GIORDANO, S

“…Osteosarcoma is the most common malignant bone neoplasia occurring in young patients in the first two decades of life, and represents 20% of all primitive…”
Get full text

High-Dose Chemotherapy in the Treatment of Relapsed Osteosarcoma: An Italian Sarcoma Group Study by FAGIOLI, F, AGLIETTA, M, MADON, E, TIENGHI, A, FERRARI, S, BRACH DEL PREVER, A, VASSALLO, E, PALMERO, A, BIASIN, E, BACCI, G, PICCI, P

“…To study the feasibility and activity of two courses of high-dose chemotherapy (HDCT) in patients with osteosarcoma in metastatic relapse. Patients with…”
Get full text

Odontogenic tumors in childhood: a retrospective study of 86 treated cases. Importance of a correct histopathologic diagnosis by Mortellaro, C, Berrone, M, Turatti, G, Rimondini, L, Brach Del Prever, A, Canavese, F, Pucci, A, Farronato, G

“…The odontogenic tumors are an unusual group of lesions of the jaws derived from embryologic tooth-forming tissues and presenting in a large number of…”
Get full text

Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin by Bacci, G, Ferrari, S, Delepine, N, Bertoni, F, Picci, P, Mercuri, M, Bacchini, P, Brach del Prever, A, Tienghi, A, Comandone, A, Campanacci, M

“…In osteosarcoma of the extremity, a strong correlation between chemotherapy-induced necrosis and prognosis has been reported. The aim of this study was to…”
Get more information

Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities by Picci, P, Böhling, T, Bacci, G, Ferrari, S, Sangiorgi, L, Mercuri, M, Ruggieri, P, Manfrini, M, Ferraro, A, Casadei, R, Benassi, M S, Mancini, A F, Rosito, P, Cazzola, A, Barbieri, E, Tienghi, A, Brach del Prever, A, Comandone, A, Bacchini, P, Bertoni, F

“…This study was performed to assess the prognostic value of the proposed histopathologic method to evaluate the response of the primary tumor to preoperative…”
Get more information

Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy by Ferrari, S., Bacci, G., Picci, P., Mercuri, M., Briccoli, A., Pinto, D., Gasbarrini, A., Tienghi, A., del Prever, A. Brach

“…Background Most of the studies of the treatment of non-metastatic osteosarcoma of the extremity have reported results in terms of probability of survival up to…”
Get full text

Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcoma by Ferrari, S., del Prever, A. Brach, Palmerini, E., Staals, E., Berta, M., Balladelli, A., Picci, P., Fagioli, F., Bacci, G., Vanel, D.

“…Aim To determine activity and toxicity of high‐dose ifosfamide (HDIFO) in recurrent or advanced Ewing sarcoma family tumors (EFT). Methods Thirty‐seven EFT…”
Get full text

Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing’s family tumours by Luksch, R, Grignani, G, Fagioli, F, del Prever, A. Brach, Podda, M, Aliberti, S, Casanova, M, Prete, A, Hanau, G, Tamburini, A, Allione, P, Tienghi, A, Ferrari, S, Collini, P, Marchianò, A, Gandola, L, Aglietta, M, Madon, E, Picci, P, Fossati-Bellani, F

“…Abstract The aim of the study was to determine the activity and toxicity of melphalan as a single agent given in up-front therapy for patients with…”
Get full text

Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies by Bacci, G, Picci, P, Ferrari, S, Casadei, R, Brach Del Prever, A, Tienghi, A, Mancini, A

“…The results of two sequential studies of neoadjuvant chemotherapy for osteosarcoma of the extremities performed at Rizzoli Institute between 1986 and 1991 in…”
Get more information

Oral manifestations of langerhans cell histiocytosis in a pediatric population: a clinical and histological study of 8 patients by Mortellaro, C, Pucci, A, Palmeri, A, Lucchina, A Greco, Berta, M, Celeste, A, Costantino, S, Del Prever, A Brach, Forni, M

“…Langerhans Cell Histiocytosis is a rare and protean disease of unknown etiology, clinically characterized by single or multiple osteolytic and/or soft tissue…”
Get full text

Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin by Bacci, G, Picci, P, Ruggieri, P, Mercuri, M, Avella, M, Capanna, R, Brach Del Prever, A, Mancini, A, Gherlinzoni, F, Padovani, G

“…Between March 1983 and June 1986 127 patients with localized osteosarcoma of the extremity were treated with neoadjuvant chemotherapy. Preoperative…”
Get more information

Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcoma by Miniero, R, Brach del Prever, A, Vassallo, E, Nesi, F, Busca, A, Fagioli, F, Albiani, R, Picci, P, Bacci, G, Madon, E

“…An Italian-Scandinavian treatment and research protocol with high-dose chemotherapy and double peripheral blood stem cell (PBSC) transplantation has been…”
Get full text

Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Results in 28 patients by Bacci, G, Picci, P, Ferrari, S, Sangiorgi, L, Zanone, A, Brach del Prever, A

“…28 patients with telangiectatic osteogenic sarcoma of the extremities were treated between March 1983 and March 1990 with neoadjuvant chemotherapy according to…”
Get more information

Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high‐risk osteosarcoma patients by Massimo, Berger, Giovanni, Grignani, Stefano, Ferrari, Eleonora, Biasin, Adalberto, Brach del Prever, Sandra, Aliberti, Francesco, Saglio, Massimo, Aglietta, Franca, Fagioli

“…BACKGROUND: A phase 2 trial was carried out to assess the antineoplastic activity of 2 courses of cyclophosphamide‐etoposide in relapsed osteosarcoma patients…”
Get full text

Growth hormone treatment in irradiated children with brain tumors by Corrias, A, Picco, P, Einaudi, S, de Sanctis, L, Besenzon, L, Garrè, M L, Brach del Prever, A, de Sanctis, C

“…We assessed the efficacy of GH treatment in 25 GH deficient patients irradiated for brain tumors (eight with glioma cranio-irradiated, eleven with…”
Get more information

CNS-85 trial: a cooperative pediatric CNS tumor study--results of treatment of medulloblastoma patients by Pezzotta, S, Cordero di Montezemolo, L, Knerich, R, Arrigoni, M, Barbara, A, Besenzon, L, Brach del Prever, A, Fidani, P, Locatelli, D, Loiacono, G, Magrassi, L, Perilongo, G, Rigobello, L, Urgesi, A, Madon, E

“…Between 1985 and 1989, 38 children with newly diagnosed medulloblastoma entered our therapeutic protocol. After surgery and postoperative staging assessments,…”
Get full text

Secondary tumors in bone sarcomas after treatment with chemotherapy by Ferrari, C, Bohling, T, Benassi, M S, Ferraro, A, Gamberi, G, Bacci, G, Del prever, A b, Sangiorgi, L, Ragazzini, P, Sollazzo, M R, Balladelli, A, Picci, P

“…New oncologic treatments have improved survival in osteosarcoma and Ewing's sarcoma. However, these treatments may cause secondary malignancies after…”
Get more information

The outcome of Wilms' tumor in infants. Italy 1970-79 by Pastore, G, Cordero di Montezemolo, L, Brach del Prever, A, Bartolozzi, G, Carli, M, Castello, M, Ceci, A, Fossati-Bellani, F, Guazzelli, C, Lo Curto, M, Madon, E, Marchi, A, Massolo, F, Mori, P G, Paolucci, G, Pianca, C, Rosati, M, Tamaro, P

“…Thirty-four infants under 1 year of age with Wilms' tumor were diagnosed and treated in 14 Italian pediatric oncology units during 1970-79. The 3-year survival…”
Get more information

No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies by Bacci, G, Picci, P, Ruggieri, P, Ferrari, S, Mercuri, M, Fabbri, N, Rosito, P, Barbieri, E, Ferraro, A, Casadei, R

“…Between January 1988 and December 1990, 74 patients with localized Ewing's sarcoma of bone were treated with a new protocol that consisted of an initial 6-week…”
Get more information